Bristol Myers Squibb has expanded its push into radiopharmaceuticals by licensing a prostate cancer therapy developed by Swiss biotech Philochem in a deal that includes an upfront payment of $350 ...

Paper products manufacturer International Paper announced a series of changes to improve cost efficiency, strengthen customer service and sustain a competitive supply position as part of its ongoing ...